血管内温度管理治疗重症热射病的可行性与安全性:一项前瞻性多中心先导研究
该前瞻性多中心先导研究在10家三级医院的重症监护与急诊医学中心开展,纳入两个夏季住院的重症热射病患者。5个中心按设备可及性被前瞻性分配进行常规降温(对照组8例),另5个中心进行常规降温联合血管内温度管理(血管内温度管理组13例)。尽管血管内温度管理组初始体温更高,全部患者均在24小时内达到37°C目标温度,而对照组仅50%达到37°C(p<0.01);血管内温度管理组入院后首个24小时序贯器官衰竭评估评分显著下降(4.0 vs 1.5;p=0.04),住院期间严重不良事件更少。出院时和入院后30天的良好结局百分比无统计学显著差异。作者认为血管内温度管理联合常规降温治疗重症热射病安全可行,更好的温度管理可能有助于预防器官衰竭,需大规模随机对照试验验证。
要点
- 血管内温度管理组13例全部在24小时内达到37°C目标温度,对照组8例中仅50%达到37°C(p<0.01)。
- 血管内温度管理组入院后首个24小时序贯器官衰竭评估评分下降4.0 vs 1.5(p=0.04)。
- 血管内温度管理组住院期间严重不良事件少于对照组。
- 出院时和入院后30天良好结局百分比两组无统计学显著差异。
- 作者认为血管内温度管理联合常规降温治疗重症热射病安全可行,需大规模随机对照试验验证。
适用人群与场景
- 两个夏季住院的重症热射病患者,来自10家三级医院的重症监护与急诊医学中心。
诊断标准与关键阈值
- 目标温度37°C,需在24小时内达到。
处置流程与药物剂量
- 对照组(5个中心,8例):常规降温。
- 血管内温度管理组(5个中心,13例):常规降温联合血管内温度管理。
- 中心分组依据设备可及性前瞻性分配。
研究设计与关键结果
- 研究类型:前瞻性多中心先导研究;10家三级医院;重症热射病患者;对照组8例,血管内温度管理组13例。
- 主要降温终点:血管内温度管理组全部患者24小时内达到37°C目标温度,对照组仅50%达到37°C(p<0.01)。
- 序贯器官衰竭评估评分:入院后首个24小时血管内温度管理组下降4.0 vs 1.5(p=0.04)。
- 严重不良事件:血管内温度管理组住院期间少于对照组。
- 出院时和入院后30天良好结局百分比:两组无统计学显著差异。
证据类型、等级与局限
- 证据类型:前瞻性多中心先导研究。
- 局限:原文未报告局限性;作者指出需大规模随机对照试验验证 findings。
对床旁实践的改变
- 作者认为血管内温度管理联合常规降温治疗重症热射病安全可行。
- 作者认为更好的温度管理可能有助于预防器官衰竭。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Heat stroke is a life-threatening condition with high mortality and morbidity. Although several cooling methods have been reported, the feasibility and safety of treating heat stroke using intravascular temperature management are unclear. This study evaluated the efficacies of conventional treatment with or without intravascular temperature management for severe heat stroke.
DESIGN: Prospective multicenter study.
SETTING: Critical care and emergency medical centers at 10 tertiary hospitals.
PATIENTS: Patients with severe heat stroke hospitalized during two summers.
INTERVENTIONS: Conventional cooling with or without intravascular temperature management.
MEASUREMENTS AND MAIN RESULTS: Cooling efficacy, Sequential Organ Failure Assessment score, occurrence rate of serious adverse events, and prognosis based on the modified Rankin Scale and Cerebral Performance Category. Patient outcomes were compared between five centers that were prospectively assigned to perform conventional cooling (control group: eight patients) and five centers that were assigned to perform conventional cooling plus intravascular temperature management (intravascular temperature management group: 13 patients), based on equipment availability. Despite their higher initial temperatures, all patients in the intravascular temperature management group reached the target temperature of 37°C within 24 hours, although only 50% of the patients in the control group reached 37°C (p < 0.01). The intravascular temperature management group also had a significant decrease in the Sequential Organ Failure Assessment score during the first 24 hours after admission (4.0 vs 1.5; p = 0.04). Furthermore, the intravascular temperature management group experienced fewer serious adverse events during their hospitalization, compared with the control group. The percentages of favorable outcomes at discharge and 30 days after admission were not statistically significant.
CONCLUSIONS: The combination of intravascular temperature management and conventional cooling was safe and feasible for treating severe heat stroke. The results indicate that better temperature management may help prevent organ failure. A large randomized controlled trial is needed to validate our findings.
参考来源
- Yokobori S, Koido Y, Shishido H, et al. Feasibility and Safety of Intravascular Temperature Management for Severe Heat Stroke: A Prospective Multicenter Pilot Study. Crit Care Med. 2018. PMID: 29624537. doi:10.1097/CCM.0000000000003153
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。